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The association between a history of renal insufficiency and poor outcome in patients with acute coronary syndrome (ACS) is well known. However, little information is available about in-hospital worsening of renal function. Our goal was to 
determine the prognostic impact of in-hospital worsening of renal function in patients with ACS.  
A total of 1228 patients consecutively admitted with ACS from January 2004 to March 2007 were reviewed. Patients deceased in hospital and patients with < 2 analysis and/or without creatinine value on admission were excluded. The selected 
patients were classified into 2 groups. Group I included patients with an increase in creatinine <0.5 mg/dL. Group II included patients with an increase in creatinine ≥ 0.5 mg/dL. The primary endpoint was 6-month mortality from any cause.  
In-hospital worsening of renal function is associated with increased 6-month mortality in patients with ACS.  
Group I (n=1028) Grupo II (n=106) p 
Age (years) 63.15 ± 12.9 74.08 ± 8.8 <0.0001 
Female sex 228 (26.1%) 42 (39.6%) 0.003 
CV risk factors: 
  Diabetes Mellitus 
  Hypertension 













Previous renal insufficiency 204 (19.8%) 67 (63.5%) <0.0001 
CV history: 
  Previous AMI 
  Previous PCI 
  Previous CABG 
  Peripheral arterial disease 




















  Heart rate (bpm) 
  SAP (mmHg) 
  KK> 1 
 
76 ± 18 
138 ± 26 
189 (18.4%) 
 
84 ± 21 






 Left ventricular dysfunction 610 (59.4%) 85 (80.8%) <0.0001 
Moratlity predictors at 180 days – Multivariate analysis  
Of the 1134 patients finally selected, 1028 belonged to group I and 106 to group II.  
Mortality at 180 days (M180days) – Kaplan – Meier curves 
P <0.0001 
Group I (n=1028) Group II (n=106) p 
In-hospital medical therapy: 
  AAS 
  Clopidogrel 
  LMWH 
  UFH 
  iECA 
  β-blocker 
  Statin 
  Nitrates 































Coronography 729 (70.9%) 58 (54.7%) 0.001 
PCI 334 (32.5%) 21 (19.8%) 0.001 
Medical therapy at discharge: 
  AAS 
  Clopidogrel 
  iECA 
  β-blocker 
  Statin 
  Nitrates 
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